MLchartDataset catalogue

111In-Zevalin

Term · Oncology and biomedicine · MLC-T-ONC-000003

A radiolabeled monoclonal antibody used to find certain types of B-cell non-Hodgkin lymphoma. It is also being studied in the diagnosis of other types of B-cell tumors. 111In-Zevalin is made up of the monoclonal antibody ibritumomab plus the radioisotope indium In 111. It binds to a protein called CD20, which is found on B cells. A machine is used to find which cells in the body have taken up 111In-Zevalin. 111In-Zevalin is a type of radioimmunoconjugate. Also called 111In-ibritumomab tiuxetan and indium In 111-ibritumomab tiuxetan.

Table 1. Record
IdentifierMLC-T-ONC-000003
FieldOncology and biomedicine
Synonyms111In-ibritumomab tiuxetan; indium In 111-ibritumomab tiuxetan
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-000003",
  "term": "111In-Zevalin",
  "field": "Oncology and biomedicine",
  "definition": "A radiolabeled monoclonal antibody used to find certain types of B-cell non-Hodgkin lymphoma. It is also being studied in the diagnosis of other types of B-cell tumors. 111In-Zevalin is made up of the monoclonal antibody ibritumomab plus the radioisotope indium In 111. It binds to a protein called CD20, which is found on B cells. A machine is used to find which cells in the body have taken up 111In-Zevalin. 111In-Zevalin is a type of radioimmunoconjugate. Also called 111In-ibritumomab tiuxetan and indium In 111-ibritumomab tiuxetan.",
  "synonyms": [
    "111In-ibritumomab tiuxetan",
    "indium In 111-ibritumomab tiuxetan"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/111in-zevalin/"
}

Record 3 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.